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Objectives: The objective of the study was to evaluate the therapeutic itinerary of patients
treated in a specialized center, including its trajectory in seeking treatment and their clinical
and  epidemiological characteristics.
Methods: This is a cross-sectional prospective descriptive study; patients with colorectal
cancer aged over 18 years and who signed the consent form were included in the analysis.
Tumor characteristics, such as staging and tumor features; epidemiological characteristics
such as age, gender, profession and itinerary in the form of the number of clinical visits
needed to obtain the diagnosis; the main symptoms; and mean time between diagnosis and
onset of treatment were evaluated.
Results: 34% of patients initially sought primary care (ﬁrst level of care in the public health
system) and 50% were diagnosed in secondary care (second level of care in the public health
system); the mean number of visits until obtaining a diagnosis was 2.5 times; and 52% of
patients received palliative therapy and 40% had a stage IV diagnosis.
Conclusions: The mean time between the diagnosis and the onset of treatment is in line
with  the recommendations of the Ministry of Health of Brazil. However, it was found that
the  patients are unaware of the symptoms of the disease, since the mean time between the
onset  of symptoms until the decision to visit the doctor was 177 days – which may have
been a determining factor for a diagnosis in an advanced stage of disease.©  2016 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. Thisis  an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
 The study was conducted at the Graduate Program in Health Promotion, Universidade de Santa Cruz do Sul, Santa Cruz do Sul, RS,
razil.
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Itinerário  terapêutico  de  pacientes  com  câncer  colorretal  tratados  no
interior  do  Rio  Grande  do  Sul
Palavras-chave:
Neoplasias colorretais
Epidemiologia
Estadiamento de neoplasia
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Objetivos: O objetivo do estudo foi avaliar o itinerário terapêutico de pacientes tratados
em  um centro especializado, compreendendo sua trajetória na busca do tratamento e as
características clínicas e epidemiológicas.
Métodos: estudo descritivo prospectivo transversal; foram incluídos na análise pacientes
portadores de câncer colorretal (CCR) maiores de 18 anos que assinaram o termo de con-
sentimento. Foram avaliadas características tumorais, como estadiamento e características
do  tumor; características epidemiológicas como idade, sexo e proﬁssão e a trajetória como
número de consultas até o diagnóstico, principais sintomas e tempo médio entre o diag-
nóstico e início do tratamento.
Resultados: 34% dos pacientes procuraram inicialmente a atenc¸ão primária (primeiro nível
de  atenc¸ão na saúde pública), 50% receberam o diagnóstico na atenc¸ão secundária (segundo
nível de atenc¸ão na saúde pública), a média de consultas até o diagnóstico foi de 2,5 vezes,
52%  dos pacientes ﬁzeram terapia paliativa e 40% ﬁzeram diagnóstico em estádio IV.
Conclusões: o tempo médio entre o diagnóstico e o início do tratamento está de acordo
com  o recomendado pelo Ministério da Saúde do Brasil; entretanto, identiﬁcou-se que os
pacientes desconhecem os sintomas da doenc¸a, uma vez que a média de tempo entre o
início dos sintomas até a tomada de decisão de procurar um médico foi de 177 dias, o que
pode ter sido determinante para um diagnóstico na fase avanc¸ada da doenc¸a.
©  2016 Sociedade Brasileira de Coloproctologia. Publicado por Elsevier Editora Ltda. Este
é  um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
Colorectal cancer (CRC) is the third most common malignancy
in humans. This disease is considered a serious public health
problem because of its huge socioeconomic impact on soci-
ety and by requiring an individualized, long, exhausting and
expensive treatment. The low income and lack of health poli-
cies to alert the population are crucial for an early diagnosis.1
As to 2014, the National Cancer Institute (INCA) estimated
the occurrence of 32,600 new cases, 15,070 in men  and 17,530
in women, accounting for 15.44 new cases per 100,000 men  and
17.24 new cases per 100,000 women. In the South region, CRC
is the third most common cancer in men  (20.43/100,000) and
the second most common in women (21.85/100,000). In 2011,
14,016 deaths (6818 men  and 7198 women) were recorded in
Brazil.2
These alarming data can be directly related to a late diagno-
sis of the disease and mainly related to the difﬁculty to offer an
adequate care. The therapeutic itinerary is a way to know the
trajectory of the disease process in seeking medical attention
in such a way that the patient and his/her family can under-
stand. In health care services difﬁculties can arise in the ﬁeld
of organization, which is a barrier to the provision of a more
effective care for patients.3
Understanding of the timing and how individuals seek
health care is a way to organize and evaluate health systems
4with a view to conducting a planning of the critical points.
Studies involving knowledge of the therapeutic itinerary of
patients with CRC are extremely important, but such papers
are still scarce.5(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Based on data in the literature and in the face of the few
studies published on this topic in oncology, the aim of this
study was to evaluate the therapeutic itinerary of patients
with CRC treated in a specialized center, as a way to under-
stand the trajectory of each patient and his/her clinical and
epidemiological characteristics.
Methodology
This is a prospective, descriptive cross-sectional study which
was conducted at the Integrated Oncology Center, Hospital
Ana Nery, located in Santa Cruz do Sul/RS. This hospital is
a reference in cancer treatment by the Uniﬁed Health Sys-
tem (Sistema Uniﬁcado de Saúde – SUS), and its database is
connected to the National Cancer Institute (INCA). The hos-
pital covers about 820,000 people in the regions of Vale do
Rio Pardo, Central Serra, and Carbonífera. On average, the
Integrated Oncology Center serves 950 chemotherapy patients
(94% by SUS). In radiotherapy, the Center serves about 100
patients per month (84.7% SUS). The data collection began in
November 2012 and was completed in April 2014. This study
was  approved by the Research Ethics Committee (CEP) of the
Universidade de Santa Cruz do Sul.
Patients with CRC with conﬁrmation of the disease by
biopsy, aged over 18 years who and signed a free and informed
consent were included in the survey. An interview face-to-
face took place and, by this instrument, the participants
were asked about epidemiological information such as age,
gender (male/female), skin color (white/non-white), family
income (number of minimum wages), profession, marital
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Table 2 – Symptoms that led our patients to seek health
care.
Symptom n◦ %
Abdominal pain 30 60
Emaciation 33 66
Blood in the stool 23 46
Diarrhea 19 38
Cold 23 46
Vomit 10 20
Fatigue 12 24
Lack of appetite 23 46
Pallor 25 50
Pain when defecating 16 32
Rectal pain 20 40
Palpable abdominal tumor 16 32
Stools with red blood 17 34
Mucus in the stool 13 26
Melena 21 42j coloproctol (rio j
tatus (accompanied/unaccompanied), diabetes (yes/no),
amily history of CRC (yes/no), family history of other types
f cancer (yes/no), time between onset of symptoms and
he ﬁrst health service sought (days), type of health care
ervice sought for the ﬁrst consultation (primary, secondary
r tertiary care), number of medical visits to establish the
iagnosis, and service where the diagnosis was carried out
primary, secondary or tertiary care). During the interview,
he patients were informed that the data would be used for
cientiﬁc research, without any personal return.
In addition to the interview, a review of medical records
as performed. The data from medical records were evaluated
nd transcribed to a data collection form previously prepared.
n the medical records, we evaluated the primary site of dis-
ase (colon/rectum), date of onset of treatment and stage of
evelopment according to the TNM classiﬁcation, issued by
he International Union for Cancer Control (UICC), where T
efers to the extent of the tumor, N to the absence or presence
f metastases in regional lymph nodes, and M to the absence
r presence of distant metastases. Adding numbers to each of
hose letters can also indicate the extent of malignancy.6
tatistical  analysis
ll information was encoded and stored anonymously in a
atabase created for this purpose. Clinical and epidemiolog-
cal data were stored in a database created in the software
tatistical Package for Social Sciences (SPSS), version 20.0
SPSS Inc., Chicago, IL) for statistical analysis. Our results were
escribed using descriptive statistics (absolute numbers, fre-
uencies and means).
esults
n total, 50 subjects participated in this study, with a mean
ge of 56 (±12.7) years. Table 1 lists the epidemiological char-
cteristics of the patients. It was found that most patients
ere Caucasian and had a family income of up to 3 min-
mum wages. Among the professions cited by patients, the
ost frequent were agriculture (Table 1).
Regarding the tests for the diagnosis of CRC, 38 (76%)
articipants had never been submitted to, or did not know,
olonoscopy. 48% had never been screened for occult blood in
he stool.
Table 1 – Epidemiological characteristics of patients with
colorectal cancer.
Characteristic n◦ %
Male gender 28 56
White skin color 39 78
Income (up to 3 minimum wages) 48 96
Profession (farmers) 19 38
Marital status (accompanied) 36 72
Family history of CRC 09 18
Family history of other types of cancer 22 44Fever 10 20
Among the symptoms causing the visit of patients to the
health service, abdominal pain, and weight loss were the most
frequently cited (Table 2).
The mean time between the onset of symptoms and the
decision to seek a health service was 177 ± 336.88 days, ran-
ging from 2 to 2160 days and with a median of 60 days. On
average, each patient visited the doctor at least 2.5 (±0.6) times
between the initial consultation and the establishment of the
diagnosis. The mean time between the ﬁrst consultation with
the chemotherapy service and the onset of treatment was 32
(±33.0) days. Among the patients studied, 13 (26%) were being
medicated simultaneously with radiotherapy and chemother-
apy.
In Fig. 1, one can see the ﬁrst type of service sought by
patients after making the decision to seek a doctor. Regarding
the service responsible for the diagnosis of cancer, it was found
that in 50% of cases this diagnosis was conﬁrmed in a sec-
ondary care service. Fig. 2 shows the trajectory of each patient.
In Table 3, the characteristics related to the tumor and the
type of treatment. 52% of patients received palliative therapy
and 40% were diagnosed with a stage IV cancer.34%
34%
22%
10%
Primary care
Secondary care
Tertiary care
Could not inform
Fig. 1 – Type of service sought for a ﬁrst visit by patients
with CRC after the decision to seek medical attention.
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17 visits
n=4
n=5
n=16
n=1 n=1
n=9
n=2 n=1
n=2
n=2 n=1
n=2
2 diagnoses
2 diagnoses
1 diagnoses4 diagnoses
7 diagnoses
12 diagnoses
1 diagnoses
3 diagnoses
Primary attention Secondary attention Tertiary attention
2 diagnoses
1 diagnoses 1 diagnoses
1 diagnoses
1 diagnoses
1 diagnoses
1 diagnoses
n=1 n=1
n=2
n=1n=8
17 visits
11 visits
2 diagnoses
Fig. 2 – Type of service sought in a ﬁrst visit by patients w
Table 3 – Clinical characteristics of patients.
Characteristic n◦ %
Site of the primary tumor – colon 32 64
Staging
II 16 32
III 13 26
IV 20 40
Purpose of treatment
Previous 02 04
Adjuvant 21 42
Palliative 26 52
Without information 01 02
Pathology
Well differentiated 05 10
Moderately differentiated 31 62
Poorly differentiated 02 04
Invasive 06 12
No information 06 12
Discussion
CRC is a prevalent malignancy worldwide, affecting mostly
rich countries. In Brazil, there is a high incidence in the South
and Southeast regions, especially in older individuals and in
males.7
In this study, the mean age was 56 years, which is in
line with the literature ﬁndings.8,9 The exact cause of CRC is
unknown, but there is strong involvement of genetic and envi-
ronmental characteristics.10 Currently, clinical and biological
factors have been studied in order to better understand the
progression of the disease.11Malignancies have been associated with the use of pes-
ticides. The chronic effect of these diseases occurs through
the respiratory, dermal and digestive tract. Pesticides which
present organochlorinated compounds in their formulationith CRC after the decision to seek medical attention.
are retained in tissues, and some studies have shown that such
agents are associated with malignancies.12 In this study, a high
prevalence of farmers (38%) diagnosed with CRC was observed.
The regions where this study was conducted have an econ-
omy based on tobacco and rice farming, which explains the
high frequency of individuals who report farming as a pro-
fessional activity. As described in a study conducted in São
Paulo, the second largest related professional activity was also
agriculture.13
In this study, 18% of patients reported a family history of
CRC. These ﬁgures are close to those found in the literature,
suggesting that in 20–25% of cases one can observe a family
component to CRC.14
We  observed in this study that patients are not aware
of preventive tests such as colonoscopy and fecal occult
blood, since 76% of patients had never been submitted to
colonoscopy and 48% never had a fecal occult blood test. These
ﬁgures are worrying because that mortality from CRC decrease
and that the survival of individuals affected by this disease
increase, conducting screening tests are the most effective
methods.14–16
In our study the most frequent symptoms were abdomi-
nal pain (60%) weight loss (66%) and blood in the stool (46%),
which is in line with the ﬁndings described by El-Halabi et al.
(2014).17 These authors report that weight loss, obstruction,
occult blood in the stool, abdominal pain and palpable abdom-
inal mass are common in all patients.
These data are worrying, given that the most effective
method for reducing mortality from CRC and increasing sur-
vival of individuals affected by this disease is to perform
screening tests.14 In addition to these tests, genetic tests
have been developed and used as predictive and prognostic
15,16biomarkers for CRC.
Knowing the therapeutic itinerary is to understand the per-
ception of each patient and how each one behaves in the face
of a certain situation.5 We  noted that, on average, the time
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lapsed since the onset of symptoms to the decision to seek
 health service was 177 (±336.88) days. This extended time
s not only due to a lack of knowledge of patients, but during
heir questioning it was possible to identify the private fears
nd anxieties, such as lack of time, overwork, the fear of a diag-
osis without healing chances and even the simple fact that
hey feel that certain symptoms would be considered normal.
herefore, the cultural and social factors, life experiences and
eliefs make these individuals opt for different ways to try to
olve their health problems; thus, they may resort to a special-
zed support or to self-treatment, resulting in a delay in their
emand for medical help and, as a consequence, with a late
iagnosis.18 Some studies have shown that some people con-
ult the doctor as soon as the ﬁrst signs and symptoms of the
isease appear; on the other hand, other people with similar
ymptoms do not proceed in this manner, because of ﬁnancial
ifﬁculties to get professional help.19 The time elapsed since
he onset of symptoms until the ﬁrst consultation is critical,
ecause the tumors already are in an advanced T stage.20 The
esult of a late diagnosis is the palliative chemotherapy, with
he tumor already in stage IV.
In this study, 34% of patients had their ﬁrst consultation
n primary care and 50% were diagnosed in secondary care,
fter two to three visits on average. These data show that the
ealth system is not a fragmented body, and can intercom-
unicate to pass along the information of its users, which
acilitates the diagnosis after the patient made the decision to
eek medical advice, as opposed to the ﬁndings described in
ther studies, i.e. Mendel et al. (2010)21 in which the authors
eport the precariousness of public health services and the
ack of communication of health networks.
The mean time since the ﬁrst consultation at the health
ervice until the beginning of treatment was 32 days, which
s in accordance with a Brazilian law approved in 2012 for
atients with proven malignancy. This law establishes that
very cancer patient should receive the ﬁrst treatment within
0 days after the diagnosis conﬁrmed by a medical report.22
In their study, Arribas et al. (2014)23 found that in 78% of
he patients studied the primary tumor site was the colon,
nd that 32.92% of patients had a pathology report of a well-
ifferentiated tumor. The tumor stage at diagnosis is crucial to
etermine the purpose of the treatment.24 Is very important
hat the doctor is aware of the pathology report (tumor char-
cteristics), because the tumor acts as a prognostic marker,
r indicates a worst (or better) result, regardless of treatment.
hus, one can evaluate each individual and choose an indi-
idualized therapy, according to the pathological features. The
iological behavior of the tumor, as well as factors that induce
ngiogenesis, may be considered decisive in the choice of
reatment and in predicting the individual’s response.25
onclusion
e  conclude that health systems are not fragmented because,
n average each patient had two visits, a number that is con-
idered appropriate. This shows that the services where the
tudy was carried out were able to communicate so that the
atient has a rapid diagnosis. Patients are not knowledge-
ble about screening tests; therefore, it is clear the lack of
1 6;3  6(2):91–96 95
campaigns warning on the need for an early diagnosis of CRC,
since the mean time between the onset of symptoms and the
decision to visit a doctor was of 177 days – and this may have
been decisive for a low perspective of cure, considering that
40% of subjects were in stage IV and 52% were referred to
palliative chemotherapy.
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